TYRO3 Human shRNA Plasmid Kit (Locus ID 7301)
CAT#: TL316973
TYRO3 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 5,740.00
Cited in 1 publication. |
Product images
CNY 1,999.00
CNY 2,700.00
CNY 4,070.00
Specifications
Product Data | |
Product Name | TYRO3 Human shRNA Plasmid Kit (Locus ID 7301) |
Locus ID | 7301 |
UniProt ID | Q06418 |
Synonyms | BYK; Dtk; Etk-2; Rek; RSE; Sky; Tif |
Vector | pGFP-C-shLenti |
Format | Lentiviral plasmids |
Kit Components | TYRO3 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector(Gene ID = 7301). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pGFP-C-shLenti Vector, TR30021, included for free. |
RefSeq | NM_006293, NM_001330264, NM_006293.1, NM_006293.2, NM_006293.3, BC051756, BC051756.1, BC029925, BC034960, BC049368, NM_006293.4 |
Summary | The gene is part of a 3-member transmembrane receptor kinase receptor family with a processed pseudogene distal on chromosome 15. The encoded protein is activated by the products of the growth arrest-specific gene 6 and protein S genes and is involved in controlling cell survival and proliferation, spermatogenesis, immunoregulation and phagocytosis. The encoded protein has also been identified as a cell entry factor for Ebola and Marburg viruses. [provided by RefSeq, May 2010] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (1)
The use of this RNAi has been cited in the following citations: |
---|
Oncogenic role of TYRO3 receptor tyrosine kinase in the progression of pancreatic cancer
,Morimoto, M;Horikoshi, Y;Nakaso, K;Kurashiki, T;Kitagawa, Y;Hanaki, T;Sakamoto, T;Honjo, S;Umekita, Y;Fujiwara, Y;Matsura, T;,
Cancer Lett.
,PubMed ID 31765735
[TYRO3]
|
Documents
Product Manuals |
FAQs |
SDS |